Product Information

KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.6167 per ML under NDC 00409379625. Its NADAC has been published 88 times since Mar 12, 2025.

FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 60 MG/2 ML VIAL

KETOROLAC TROMETHAMINE
$0.6167per ML

Strength

60 mg/2mL

Manufacturer

Hospira Inc.

NDC

00409379625

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA074802

FDA Approved

6/5/1997

TE Code

AP

On Market Since

10/30/2015

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 88 times since Mar 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.6167 per ML
All-time high$0.6484 (Apr 16, 2025)
All-time low$0.4543 (Feb 18, 2026)
52-week high$0.6167
52-week low$0.4543
Median price$0.5387
Average price$0.5473
Largest weekly change+11.6% (Oct 21, 2026)
Weeks tracked88
Tracking sinceMar 12, 2025

Price History

1W

0.0%

1M

+11.6%

3M

+28.3%

6M

+21.2%

1Y

+13.4%

3Y

N/A

5Y

N/A

All

-1.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.6167 per ML (NDC 00409379625), effective Nov 11, 2026.

How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has held within roughly two percent of its current level. It has been tracked across 88 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?

Since Mar 12, 2025, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $0.6484 (Apr 16, 2025), with a median of $0.5387 per ML.

Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4980 per ML — about 19% below KETOROLAC 60 MG/2 ML VIAL.

Who manufactures KETOROLAC 60 MG/2 ML VIAL?

KETOROLAC 60 MG/2 ML VIAL (NDC 00409379625) is labeled by Hospira Inc., and CMS classifies it as a generic product.